PE/Cyanine7 anti-mouse TCR β chain Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Armenian Hamster

Immunogen

Affinity purified TCR from mouse DO-11.10 cells

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)

Application Notes

H57-597 is a hamster mAb directed to an epitope of the C region of TCR ß chain¹². The H57-597 antibody does not cross-react with ?/d TCR-bearing T cells. Immobilized or soluble H57-597 antibody can activate a/ß TCR-bearing T cells. Additional reported applications (for the relevant formats) for this antibody include: immunoprecipitation², in vitro stimulation^2,3, in vivo depletion^4-6, and immunohistochemical staining of acetone-fixed frozen sections^7,8,9. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 109253-109258).

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)

1. Gascoigne NJ. 1990. J. Biol. Chem. 265:9296.
2. Kruisbeek A, et al. 1991. In Current Protocols in Immunology. pp. 3.12.1. (Costim IP)
3. Davenport C, et al. 1995. J. Immunol. 155:3742. (Costim)
4. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
5. Kummer U, et al. 2001. Immunol. Lett. 75:153. (Deplete)
6. van der Heyde HC, et al. 1995. J. Immunol. 154:3985. (Deplete)
7. Tomita K, et al. 1999. Genes Dev. 13:1203. (IHC)
8. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
9. Ponomarev ED, et al. 2007. J. Immunol. 178:39. (IHC)
10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
11. Tsukumo S, et al. 2006. J.Immunol. 177:8365. (FC) PubMed
12. Grégoire C, et al. 1991. Proc. Natl. Acad. Sci USA 88:8077.

Product Citations

1. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
2. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
3. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
4. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
5. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
6. Failer T, et al. 2022. J Clin Invest. . PubMed
7. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
8. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
9. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
10. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
11. Nieuwenhuijze A, et al. 2014. Am J Pathol. 184:184. PubMed
12. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
13. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
14. Sugimoto C, et al. 2022. Elife. 11:. PubMed
15. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
16. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
17. Krementsov DN, et al. 2018. Front Immunol. 9:1622. PubMed
18. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
19. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
20. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
21. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
22. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
23. Ribeiro-Gomes F, et al. 2015. Cell Death Dis. 6: 2018. PubMed
24. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
25. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
26. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
27. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
28. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
29. Kyburz A, et al. 2017. Clin Exp Allergy. 47:1331. PubMed
30. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
31. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
32. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
33. Sadik A, et al. 2020. Cell. 1252:182. PubMed
34. Sencio V, et al. 2020. Cell Reports. 30(9):2934-2947. PubMed
35. Udden SN et al. 2019. eLife. 8 pii: e40396. PubMed
36. Matas-Rico E, et al. 2021. Cell Rep. 37:110013. PubMed
37. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
38. Li J, et al. 2020. Development. :. PubMed
39. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
40. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
41. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
42. Thornton T, et al. 2016. Nat Commun. 7:10553. PubMed
43. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
44. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
45. Wang X, et al. 2021. Cell. 184:5357. PubMed
46. Baars MJD, et al. 2020. Eur J Immunol. . PubMed
47. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
48. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
49. Sell S, et al. 2015. PLoS Pathog. 11:1004481. PubMed
50. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
51. Wang X, et al. 2022. Elife. 11:. PubMed
52. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
53. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
54. Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed
55. Liang Z, et al. 2022. iScience. 25:105233. PubMed
56. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
57. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed

RRID

AB_893627 (BioLegend Cat. No. 109221)
AB_893625 (BioLegend Cat. No. 109222)

Antigen Details

Structure

Ig superfamily, CD3/TCR complex with CD3 and TCR α subunit

Distribution

Majority of T cells and thymocytes (correlated to differentiation)

Function

Antigen recognition, T cell activation

Ligand/Receptor

Peptide bound-MHC class I and II

Antigen References

1. Davis MM, et al. 1998. Ann. Rev. Immunol. 16:523.
2. Huppa JB, et al. 2003. Nat. Immunol. 4:749.
3. Kubo R, et al. 1989. J. Immunol. 142:2736.

Gene ID

21577 View all products for this Gene ID

UniProt

View information about TCR beta chain on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis